Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A German, non-Interventional study of NEPA (fixed dose Netupitant/Palonosetron) for the prevention of chemotherapy induced nausea and vomiting

Trial Profile

A German, non-Interventional study of NEPA (fixed dose Netupitant/Palonosetron) for the prevention of chemotherapy induced nausea and vomiting

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Dec 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Netupitant/palonosetron (Primary)
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Therapeutic Use
  • Acronyms AkyPRO
  • Most Recent Events

    • 14 Dec 2019 Interim analysis in the subgroup of breast cancer patients presented at the 42nd Annual San Antonio Breast Cancer Symposium
    • 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
    • 12 Dec 2017 Results (n=1959) assessing efficacy and impact on quality of life in adult cancer patients by patient-related outcomes (PRO) and physicians personal assessment under real life conditions, were presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AskTheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top